127 related articles for article (PubMed ID: 27975069)
21. Induction of cytotoxic T-lymphocytes specific for malignant glioma by HLA dimer-based artificial antigen-presenting cells.
Xiaobing J; Xiaoling L; Ruen L; Fangcheng Z; Hongyang Z
Cancer Biother Radiopharm; 2007 Dec; 22(6):826-35. PubMed ID: 18158774
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity.
Makrigiannis AP; Hoskin DW
J Immunol; 1997 Nov; 159(10):4700-7. PubMed ID: 9366393
[TBL] [Abstract][Full Text] [Related]
23. Identification of CD19 and CD20 peptides for induction of antigen-specific CTLs against B-cell malignancies.
Bae J; Martinson JA; Klingemann HG
Clin Cancer Res; 2005 Feb; 11(4):1629-38. PubMed ID: 15746068
[TBL] [Abstract][Full Text] [Related]
24. CD2-CD48 interactions promote cytotoxic T lymphocyte induction and function: anti-CD2 and anti-CD48 antibodies impair cytokine synthesis, proliferation, target recognition/adhesion, and cytotoxicity.
Musgrave BL; Watson CL; Hoskin DW
J Interferon Cytokine Res; 2003 Feb; 23(2):67-81. PubMed ID: 12744772
[TBL] [Abstract][Full Text] [Related]
25. Induction of IL-17 production from human peripheral blood CD4+ cells by asbestos exposure.
Maeda M; Chen Y; Lee S; Kumagai-Takei N; Yoshitome K; Matsuzaki H; Yamamoto S; Hatayama T; Ikeda M; Nishimura Y; Otsuki T
Int J Oncol; 2017 Jun; 50(6):2024-2032. PubMed ID: 28498408
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus-transformed B-cells as efficient antigen presenting cells to propagate Aspergillus-specific cytotoxic T-lymphocytes.
Ramadan G
Egypt J Immunol; 2008; 15(1):145-57. PubMed ID: 20306679
[TBL] [Abstract][Full Text] [Related]
27. Induction of granulysin in CD8+ T cells by IL-21 and IL-15 is suppressed by human immunodeficiency virus-1.
Hogg AE; Bowick GC; Herzog NK; Cloyd MW; Endsley JJ
J Leukoc Biol; 2009 Nov; 86(5):1191-203. PubMed ID: 19687290
[TBL] [Abstract][Full Text] [Related]
28. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs.
Cruz-Guilloty F; Pipkin ME; Djuretic IM; Levanon D; Lotem J; Lichtenheld MG; Groner Y; Rao A
J Exp Med; 2009 Jan; 206(1):51-9. PubMed ID: 19139168
[TBL] [Abstract][Full Text] [Related]
29. Generation of IL-2-dependent cytolytic T lymphocytes (CTLs) with altered TCR responses derived from antigen-dependent CTL clones.
Gullo CA; Esser MT; Fuller CL; Lam Braciale V
J Immunol; 1999 Jun; 162(11):6466-72. PubMed ID: 10352261
[TBL] [Abstract][Full Text] [Related]
30. Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12.
Okamoto I; Kohno K; Tanimoto T; Ikegami H; Kurimoto M
J Immunol; 1999 Mar; 162(6):3202-11. PubMed ID: 10092771
[TBL] [Abstract][Full Text] [Related]
31. Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens.
Angoulvant D; Clerc A; Benchalal S; Galambrun C; Farre A; Bertrand Y; Eljaafari A
Biorheology; 2004; 41(3-4):469-76. PubMed ID: 15299278
[TBL] [Abstract][Full Text] [Related]
32. Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes.
Mehrotra PT; Wu D; Crim JA; Mostowski HS; Siegel JP
J Immunol; 1993 Sep; 151(5):2444-52. PubMed ID: 8103066
[TBL] [Abstract][Full Text] [Related]
33. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
34. Reduced lysis by CD8+ cytotoxic T cells in mixed lymphocyte reactions induced via CD4+ T cells exposed to chemically modified antigen presenting cells.
Corlett L; Davies DH
Immunology; 1995 Mar; 84(3):488-94. PubMed ID: 7751034
[TBL] [Abstract][Full Text] [Related]
35. Late dendritic cells are still able to evoke a potent alloreactive CTL response.
Repnik U; Bergant M; Wraber B; Jeras M
Immunobiology; 2008; 213(1):51-64. PubMed ID: 18207027
[TBL] [Abstract][Full Text] [Related]
36. Synergy between interleukin 4 and interleukin 2 conveys resistance to cyclosporin A during primary in vitro activation of murine CD8 cytotoxic T cell precursors.
Bubeck R; Miethke T; Heeg K; Wagner H
Eur J Immunol; 1989 Apr; 19(4):625-30. PubMed ID: 2499483
[TBL] [Abstract][Full Text] [Related]
37. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients.
de la Barrera S; Finiasz DM; Fink S; Valdez R; Bottasso O; Balina LM; Sasiain MC
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):45-55. PubMed ID: 9207753
[TBL] [Abstract][Full Text] [Related]
38. Tumor Infiltrating T Cell Cytotoxicity Assay.
Chaoul N; Albanesi M
Methods Mol Biol; 2021; 2325():41-54. PubMed ID: 34053049
[TBL] [Abstract][Full Text] [Related]
39. Interleukin 2-independent interleukin 7 activity enhances cytotoxic immune response of HIV-1-infected individuals.
Carini C; Essex M
AIDS Res Hum Retroviruses; 1994 Feb; 10(2):121-30. PubMed ID: 7515256
[TBL] [Abstract][Full Text] [Related]
40. B7.2-Ig fusion proteins enhance IL-4-dependent differentiation of tumor-sensitized CD8+ cytotoxic T lymphocyte precursors.
Hiraoka S; Takeuchi N; Bian Y; Nakahara H; Kogo M; Dunussi-Joannopoulos K; Wolf S; Ono S; Fujiwara H
Int Immunol; 2005 Aug; 17(8):1071-9. PubMed ID: 16027141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
